Cargando…
A Reproducible Bioprinted 3D Tumor Model Serves as a Preselection Tool for CAR T Cell Therapy Optimization
Chimeric antigen receptor (CAR) T cell performance against solid tumors in mouse models and clinical trials is often less effective than predicted by CAR construct selection in two-dimensional (2D) cocultures. Three-dimensional (3D) solid tumor architecture is likely to be crucial for CAR T cell eff...
Autores principales: | Grunewald, Laura, Lam, Tobias, Andersch, Lena, Klaus, Anika, Schwiebert, Silke, Winkler, Annika, Gauert, Anton, Heeren-Hagemann, Anja I., Astrahantseff, Kathy, Klironomos, Filippos, Thomas, Alexander, Deubzer, Hedwig E., Henssen, Anton G., Eggert, Angelika, Schulte, Johannes H., Anders, Kathleen, Kloke, Lutz, Künkele, Annette |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8276678/ https://www.ncbi.nlm.nih.gov/pubmed/34267756 http://dx.doi.org/10.3389/fimmu.2021.689697 |
Ejemplares similares
-
Inhibiting Lysine Demethylase 1A Improves L1CAM-Specific CAR T Cell Therapy by Unleashing Antigen-Independent Killing via the FAS-FASL Axis
por: Sulejmani, Ornela, et al.
Publicado: (2021) -
Tumor-Derived Extracellular Vesicles Impair CD171-Specific CD4(+) CAR T Cell Efficacy
por: Ali, Solin, et al.
Publicado: (2020) -
CD171- and GD2-specific CAR-T cells potently target retinoblastoma cells in preclinical in vitro testing
por: Andersch, Lena, et al.
Publicado: (2019) -
GD2-directed bispecific trifunctional antibody outperforms dinutuximab beta in a murine model for aggressive metastasized neuroblastoma
por: Zirngibl, Felix, et al.
Publicado: (2021) -
Defining the landscape of circular RNAs in neuroblastoma unveils a global suppressive function of MYCN
por: Fuchs, Steffen, et al.
Publicado: (2023)